These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30503539)

  • 1. Utility of flow cytometry in canine primary cutaneous and matched nodal mast cell tumor.
    Sulce M; Marconato L; Martano M; Iussich S; Dentini A; Melega M; Miniscalco B; Riondato F
    Vet J; 2018 Dec; 242():15-23. PubMed ID: 30503539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis in canine cutaneous mast cell tumors.
    Simeonov R; Simeonova G
    Anal Quant Cytol Histol; 2010 Jun; 32(3):178-81. PubMed ID: 20701073
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
    Thompson JJ; Morrison JA; Pearl DL; Boston SE; Wood GA; Foster RA; Coomber BL
    Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
    Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
    Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
    Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
    Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
    Meyer A; Gruber AD; Klopfleisch R
    Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composition of lymphocyte subpopulations in normal canine lymph nodes.
    Rütgen BC; König R; Hammer SE; Groiss S; Saalmüller A; Schwendenwein I
    Vet Clin Pathol; 2015 Mar; 44(1):58-69. PubMed ID: 25512102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
    Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
    Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
    Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
    Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
    Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
    Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
    Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta-analysis.
    Freytag JO; Queiroz MR; Govoni VM; Pereira IVA; Pulz LH; de Francisco Strefezzi R; Queiroga FL; Cogliati B
    Vet Comp Oncol; 2021 Sep; 19(3):529-540. PubMed ID: 33724647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric immunophenotype of canine lymph node aspirates.
    Gibson D; Aubert I; Woods JP; Abrams-Ogg A; Kruth S; Wood RD; Bienzle D
    J Vet Intern Med; 2004; 18(5):710-7. PubMed ID: 15515589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours.
    Pulz LH; Barra CN; Kleeb SR; Xavier JG; Catão-Dias JL; Sobral RA; Fukumasu H; Strefezzi RF
    Vet Comp Oncol; 2017 Jun; 15(2):606-614. PubMed ID: 27041588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
    De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
    Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.